Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced that the U.S. Food and Drug Administration (U.S. FDA) has approved Jobevne™ (bevacizumab-nwgd), ...

Commerce & Internet Business Almanac 2025: Market Research, Statistics, Trends and Leading Companies" book from Plunkett Research Ltd has been added to ResearchAndMarkets.com's offering. A complete ...

Chief Master Sgt. of the Air Force David Flosi testifies before the House Appropriations Committee about military quality of ...

In an interview, United Auto Workers president Shawn Fain argues that the era of “free-trade” deals like NAFTA has been a ...